Analysis of TMEM174 gene expression in various renal cancer types by RNA in situ hybridization
- Authors:
- Xiujun Zhang
- Fen Hu
- Lijun Meng
- Lixia Gou
- Mengmeng Luo
View Affiliations
Affiliations: College of Life Sciences, Hebei United University, Tangshan, Hebei 063000, P.R. China, Department of Environment and Chemical Engineering, Tangshan College, Tangshan, Hebei 063000, P.R. China
- Published online on: July 30, 2014 https://doi.org/10.3892/ol.2014.2393
-
Pages:
1693-1696
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Transmembrane protein 174 (TMEM174) mRNA is easily detectable in human kidney tissues and activates AP‑1 and promotes 293T cell proliferation. In the present study, RNA in situ hybridization was used to detect TMEM174 gene expression in various malignant renal cancer and normal renal tissues. The results showed that TMEM174 exhibits differential expression in renal tissues, with a high positive rate of expression in squamous cell carcinoma with necrosis, papillary renal cell carcinoma and transitional cell carcinoma, and a low positive rate of expression in clear cell carcinoma, interstitial nephritis, undifferentiated carcinoma, retroperitoneal metastatic clear cell carcinoma, adrenal gland metastatic clear cell carcinoma, pelvic cavity metastatic chromophobe carcinoma, severe atypical hyperplasia of transitional epithelium and hyperplasia. Extremely weak expression was exhibited in collecting duct carcinoma, Wilms' tumor, chronic pyelonephritis, acute pyelonephritis, cancer adjacent normal renal tissue and normal renal tissue. In conclusion, the TMEM174 gene exhibited high expression levels in certain renal carcinomas, which may indicate that TMEM174 may have a significant role in the development and progression of these renal carcinomas.
View References
|
1
|
Wan D, Gong Y, Qin W, et al: Large-scale
cDNA transfection screening for genes related to cancer development
and progression. Proc Natl Acad Sci USA. 101:15724–15729. 2004.
|
|
2
|
Wang P, Sun B, Hao D, Zhang X, Shi T and
Ma D: Human TMEM174 that is highly expressed in kidney tissue
activates AP-1 and promotes cell proliferation. Biochem Biophys Res
Commun. 394:993–999. 2010.
|
|
3
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Manual. 6th edition. Springer-Verlag; New York:
2002
|
|
4
|
Eto M and Naito S: Molecular targeting
therapy for renal cell carcinoma. Int J Clin Oncol. 11:209–213.
2006.
|
|
5
|
Costa LJ and Drabkin HA: Renal cell
carcinoma: new developments in molecular biology and potential for
targeted therapies. Oncologist. 12:1404–1415. 2007.
|
|
6
|
Stillebroer AB, Oosterwijk E, Oyen WJ,
Mulders PF and Boerman OC: Radiolabeled antibodies in renal cell
carcinoma. Cancer Imaging. 7:179–188. 2007.
|
|
7
|
Mellado B and Gascón P: Molecular biology
of renal cell carcinoma. Clin Transl Oncol. 8:706–710. 2006.
|
|
8
|
Weight CJ, Kaouk JH, Hegarty NJ, et al:
Correlation of radiographic imaging and histopathology following
cryoablation and radio frequency ablation for renal tumors. J Urol.
179:1277–1283. 2008.
|
|
9
|
Chen X, Ruan A, Wang X, et al: miR-129-3p,
as a diagnostic and prognostic biomarker for renal cell carcinoma,
attenuates cell migration and invasion via downregulating multiple
metastasis-related genes. J Cancer Res Clin Oncol. May 7–2014.(Epub
ahead of print).
|
|
10
|
Hess J, Angel P and Schorpp-Kistner M:
AP-1 subunits: quarrel and harmony among siblings. J Cell Sci.
117:5965–5973. 2004.
|
|
11
|
Bourtchuladze R, Frenguelli B, Blendy J,
et al: Deficient long-term memory in mice with a targeted mutation
of the cAMP-responsive element-binding protein. Cell. 79:59–68.
1994.
|
|
12
|
Hu F, Meng Y, Gou L and Zhang X: Analysis
of promoters and CREB/AP-1 binding sites of the human TMEM174 gene.
Exp Ther Med. 6:1290–1294. 2013.
|
|
13
|
Jensen E: Technical review: In situ
hybridization. Anat Rec (Hoboken). 9–May;2014.(Epub ahead of
print). DOI: 10.1002/ar.22944
|
